Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Joint venture formed to develop cancer therapy

Jan. 7, 1997

NeoRx technology receives additional patent

Jan. 7, 1997

p53 proteins with altered tetramerization domains synthesized

Jan. 7, 1997

Immunex presents novel cytokine

Jan. 7, 1997

Immunex reports epithelium-derived T-cell factor polypeptides

Jan. 7, 1997

First NDA submission for NeoPharm seeks approval for two indications

Jan. 3, 1997

TxA2 antagonists modulate tumor sensitivity to platinum anticancer drugs

Jan. 3, 1997

Prenyl-protein transferase inhibitors reported by Merck & Co.

Jan. 3, 1997

U.S. IND granted for Scotia's photodynamic drug

Jan. 2, 1997

Novel antiangiogenic compounds from ADIR

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...